FDA Inspection 1277419 - Avista Pharma Solutions, Inc. dba Cambrex - July 03, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on July 3, 2025, issued by the Atlanta District Office, covering human drugs.

Company: Avista Pharma Solutions, Inc. dba Cambrex
Inspection Date: July 3, 2025
Product Type: Human Drugs
Office: Atlanta District Office

Open in Dashboard

ID · 8a4208ef-dcad-47c0-9bbd-2ab3cdc26b19